The latest biotech news

News and Trends 1 Aug 2018

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

ReViral will dedicate the funds to run two clinical trials to test whether its antiviral can help patients at high risk from RSV infections. The respiratory syncytial virus (RSV) only causes mild cold symptoms in most people. But for small children and immunosuppressed patients, it can be deadly. “There are at present no approved therapies […]

August 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Jul 2018

Recycled Forestry Waste Could Make Cosmetics, Plastics and Biofuel

An EU project is using forestry waste to make 2,3-butanediol, a chemical with a wide range of industrial applications, from perfumes to synthetic rubber and food additives. Rehap, an EU project, has found a way to produce 2,3-butanediol, a chemical building block used in a range of industrial applications, using sugars purified from forestry waste. […]

July 31, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 31 Jul 2018

Israeli Crohn’s Disease Drug Rakes in Positive Phase III Results

RedHill Biopharma has obtained positive Phase III results for its Crohn’s disease treatment, which targets a certain type of gut bacteria. Crohn’s disease is a type of inflammatory bowel disease, characterized by acute flare-ups and periods of symptom-free remission, that can affect any part of the gastrointestinal tract. It has a high prevalence for an autoimmune disease, […]

July 31, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 30 Jul 2018

This Transgenic Rice Could Prevent HIV Infections

Researchers in Spain have created a strain of genetically-engineered rice that could provide a cheap alternative to produce medicines for HIV prevention. The risk of HIV infections can be significantly reduced with oral medication. However, pricing is a big issue for people living in impoverished or developing countries who are at risk. Researchers at the […]

July 30, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Jul 2018

This Bulletproof Skin is Made of Goat Milk Spider Silk

Jalila Essaïdi is a Dutch artist and entrepreneur focused on biotech applications of spider silk, which she makes using the milk of genetically engineered goats. Spider silk is one of the strongest materials in nature. Jalila Essaïdi had her curiosity piqued when she read about the work of Randolph Lewis, a Professor at Utah State […]

July 30, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Jul 2018

EU Court of Justice Makes Restrictive Ruling on Genome Editing

Genetically-edited organisms that were until now excluded from GMO regulation will now be subject to EU GMO law, which according to experts could harm Europe’s leading position in genome editing. Following a petition from France’s Council of State, the Court of Justice of the EU has stated that mutagenesis techniques should be regulated under GMO […]

July 26, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Jul 2018

Replimune’s €85M IPO set to Boost Oncolytic Immunotherapy Pipeline

The US-UK biotech completed its $100M (€85M) IPO on the NASDAQ stock exchange to further develop ‘oncolytic’ immunotherapies that use the herpes virus to target and attack tumor tissue. Replimune’s immunotherapies use the virus to deliver proteins into tumor tissue that help it fuse with the tumor cells. When the virus fuses to tumor cells, it activates […]

July 26, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 26 Jul 2018

AI Company Raises €8.6M to Find Drugs for Rare Diseases Faster and Cheaper Than Ever

Cambridge-based Healx has raised $10M (€8.6M) in a Series A round to scale up its AI technology, which could significantly reduce the time and cost of developing drugs for rare diseases. Backed, among other investors, by the founder of Abcam, Healx plans to use the fundraising to double its workforce from 15 to over 30 […]

July 26, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jul 2018

Two Drugs as Good as Three for Treating HIV

ViiV Healthcare reports promising data from two HIV treatments with two drugs instead of the usual three, which have the potential to reduce the side effects of antiretroviral therapy in the long term. People infected with HIV are treated with lifelong antiretroviral therapy, which traditionally consists of three or more different drugs. The British […]

July 25, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jul 2018

Austrian Researchers Grow Cancerous Mini Brains in a Dish

Researchers in Vienna are growing mini brains that mimic the onset and development of brain cancer, which could be used to compare the efficacy of different treatments. Because of their cellular complexity, brain cancers have been difficult to study in animals. Glioblastoma, the most aggressive form of brain cancer, is particularly difficult to treat because […]

July 25, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 24 Jul 2018

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

Celyad has received FDA approval to start clinical trials for its CAR-T cell therapy, which is engineered to avoid side effects associated with using donor cells for this kind of treatment. The Belgian biotech has been cleared to test its CAR-T cell therapy, made from donor cells, in patients with unresectable colorectal cancer in combination […]

July 24, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 23 Jul 2018

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

UK-biotech Owen Mumford plans to launch an HIV diagnostic test in Europe that can produce an accurate result within 15 minutes. Current rapid diagnostic tests for HIV can lead to misdiagnosis, for example when steps in the procedure are not followed in the right order, or too little blood is drawn. The new test, called […]

July 23, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

Recycled Forestry Waste Could Make Cosmetics, Plastics and Biofuel

Israeli Crohn’s Disease Drug Rakes in Positive Phase III Results

This Transgenic Rice Could Prevent HIV Infections

This Bulletproof Skin is Made of Goat Milk Spider Silk

EU Court of Justice Makes Restrictive Ruling on Genome Editing

Replimune’s €85M IPO set to Boost Oncolytic Immunotherapy Pipeline

AI Company Raises €8.6M to Find Drugs for Rare Diseases Faster and Cheaper Than Ever

Two Drugs as Good as Three for Treating HIV

Austrian Researchers Grow Cancerous Mini Brains in a Dish

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

UK Biotech to Launch Rapid, Accurate HIV Test in Europe

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!